title: [Supervised off-label prescribing of topiramate for binge eating disorder within the system CAMTEA].
authors.forename: Dewi
authors.initials: D
authors.lastname: Guardia
authors.forename: Benjamin
authors.initials: B
authors.lastname: Rolland
authors.forename: Sylvie
authors.initials: S
authors.lastname: Deheul
authors.forename: Thierry
authors.initials: T
authors.lastname: Danel
authors.forename: Régis
authors.initials: R
authors.lastname: Bordet
authors.forename: Olivier
authors.initials: O
authors.lastname: Cottencin
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use; D016739:Behavior, Addictive / Q000628:therapy; D056912:Binge-Eating Disorder / Q000188:drug therapy*; D000075202:Contraindications; D058492:Drug Repositioning; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008991:Monitoring, Physiologic; D056687:Off-Label Use; D057285:Precision Medicine / Q000379:methods; D016320:Substance Abuse Treatment Centers / Q000379:methods / Q000458:organization & administration; D000077236:Topiramate
chemical_list: D019440:Anti-Obesity Agents; D000077236:Topiramate; D005632:Fructose